Related Experiment Videos
Subtotal parathyroidectomy: a possible treatment for calciphylaxis.
Gideon Bahar1, Daniel Mimouni, Meora Feinmesser
1Department of Otorhinolaryngology, Rabin Medical Center, Beilinson Campus, Petah Tiqva, Israel.
Ear, Nose, & Throat Journal
|June 7, 2003
Summary
Calciphylaxis, a rare disorder in chronic renal failure patients, causes severe skin lesions. Subtotal parathyroidectomy may improve outcomes for calciphylaxis, offering a potential treatment for this grave condition.
Area of Science:
- Nephrology
- Dermatology
- Endocrinology
Background:
- Calciphylaxis is a rare, severe condition in chronic renal failure (CRF) patients.
- It presents as ischemic necrotic skin lesions with high mortality.
- Elevated parathyroid hormone (PTH) is implicated, but its role and treatment efficacy remain unclear.
Observation:
- A case of rapidly progressive subcutaneous calcifications and ulcerations in the lower extremities of a CRF patient is presented.
- The patient experienced severe skin manifestations characteristic of calciphylaxis.
Findings:
- Subtotal parathyroidectomy led to the regression of severe skin lesions in the observed patient.
- This suggests a potential therapeutic benefit of parathyroidectomy in select calciphylaxis cases.
Implications:
- Parathyroidectomy may be a viable treatment option for calciphylaxis, warranting further investigation.
- Understanding the role of PTH in calciphylaxis can guide future therapeutic strategies.
- This case highlights the importance of considering surgical intervention for severe calciphylaxis unresponsive to other treatments.